Karl Johe - curasan AG Insider

CUR -- Germany Stock  

EUR 0.97  0.014  1.43%

  Chairman
Dr. Karl Johe Ph.D. is Chairman of the Board and Chief Scientific Officer of Neuralstem Inc. since 1996. Dr. Johe has over 15 years of research and laboratory experience. Dr. Johe is the sole inventor of Neuralstems granted stem cell patents and is responsible for the strategic planning and development of our therapeutic products. Dr. Johe received his Bachelor of Arts Degree in Chemistry and a Masters Degree from the University of Kansas. Dr. Johe received his doctorate from the Albert Einstein College of Medicine of Yeshiva University. From 1993 to January 1997 Dr. Johe served as a Staff Scientist at the Laboratory of Molecular Biology of the National Institute of Neurological Disease and Stroke in Bethesda Maryland. While holding this position Dr. Johe conducted research on the isolation of neural stem cells the elucidation of mechanisms directing cell type specification of central nervous system stem cells and the establishment of an in vitro model of mammalian neurogenesis. In evaluating Dr. Johes specific experience qualifications attributes and skills in connection with his appointment to our board we took into account his extensive experience in international science and business communities. Dr. Johe is also multilingual.
Age: 53  Chairman Since 1996      
49 6027 40 900 51  http://www.curasan.de
Johe received his doctorate from the Albert Einstein College of Medicine of Yeshiva University. From 1993 to January 1997, Dr. Johe served as a Staff Scientist at the Laboratory of Molecular Biology of the National Institute of Neurological Disease and Stroke in Bethesda, Maryland. While holding this position, Dr. Johe conducted research on the isolation of neural stem cells, the elucidation of mechanisms directing cell type specification of central nervous system stem cells and the establishment of an in vitro model of mammalian neurogenesis.

Karl Johe Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (14.06) % which means that it has lost $14.06 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (45.01) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 717 K in total debt with debt to equity ratio (D/E) of 8.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. curasan AG has Current Ratio of 1.64 which is within standard range for the sector.

Entity Summary

curasan AG develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. The company was founded in 1988 and is based in Kleinostheim, Germany. curasan AG operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 38 people.curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Lindigstrasse 4 and employs 38 people.

curasan AG Leadership Team

William Oldaker, Independent Director
David Castaneda, IR Contact
Stanley Westreich, Independent Director
Karl Johe, Chairman of the Board, Chief Scientific Officer
Scott Ogilvie, Independent Director
Catherine Sohn, Director
Richard Garr, President CEO, General Counsel, Director
Richard Daly, President CEO
Sandford Smith, Director
Jonathan Jones, CFO

Stock Performance Indicators

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Companies Directory

curasan AG Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for curasan AG and Fielmann AG. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Search macroaxis.com